Status:
COMPLETED
Impact of Probiotics in Modulation of Intestinal Microbiota
Lead Sponsor:
Maria Isabel Toulson Davisson Correia
Conditions:
Colorectal Cancer
Eligibility:
All Genders
Phase:
NA
Brief Summary
The investigators would study about impact of the administration of probiotics in the intestinal mucosa of patients undergoing resection colic, by evaluating cytokine profile by quantitative real time...
Detailed Description
Samples of colorectal cancer-free mucosa derived from patients who underwent surgical resection were investigated. Quantitative real-time polymerase chain reaction (RT-qPCR) was used to determine expr...
Eligibility Criteria
Inclusion
- if he or she were older than 18 years
- intended to undergo elective CRC resection at UFMG Hospital
Exclusion
- Patients were excluded if they were not able to receive the probiotics seven days before the operation
- if colon resection was not performed due to changes in operation strategy, or if they discontinued probiotic use on their own or
- if they removed their consent.
Key Trial Info
Start Date :
July 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT01895530
Start Date
July 1 2010
End Date
May 1 2012
Last Update
July 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UFMG Hospital
Belo Horizonte, Minas Gerais, Brazil, 30640100